Djuro Kosanovic Selected Research

N- (2- acetyl- 4,6- dimethylphenyl)- 3- (3,4- dimethylisoxazol- 5- ylsulfamoyl)thiophene- 2- carboxamide

6/2011

Therapeutic efficacy of TBC3711 in monocrotaline-induced pulmonary hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Djuro Kosanovic Research Topics

Disease

13	Pulmonary Hypertension 01/2021 - 01/2010
7	Hypoxia (Hypoxemia) 01/2022 - 01/2010
6	Vascular Remodeling 01/2021 - 09/2013
5	Pulmonary Fibrosis (Fibrosing Alveolitis) 10/2019 - 01/2013
4	Chronic Obstructive Pulmonary Disease (COPD) 01/2021 - 03/2014
4	Fibrosis (Cirrhosis) 10/2019 - 09/2013
3	Familial Primary Pulmonary Hypertension 01/2022 - 05/2011
3	COVID-19 08/2021 - 01/2021
3	Inflammation (Inflammations) 01/2021 - 11/2018
3	Lung Diseases (Lung Disease) 10/2019 - 03/2014
3	Idiopathic Pulmonary Fibrosis 11/2018 - 01/2013
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 08/2021 - 01/2021
2	Right Ventricular Hypertrophy 01/2020 - 01/2010
2	Lung Injury 10/2019 - 01/2017
1	Pulmonary edema of mountaineers 10/2021
1	Pulmonary Heart Disease (Cor Pulmonale) 03/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Emphysema 01/2021
1	Pneumonia (Pneumonitis) 10/2019
1	Heart Neoplasms 01/2019
1	Glioma (Gliomas) 11/2018
1	Ventricular Remodeling 01/2018
1	Bronchopulmonary Dysplasia 01/2018
1	Reperfusion Injury 01/2017
1	Heart Failure 01/2016
1	Interstitial Lung Diseases (Interstitial Lung Disease) 10/2015
1	Schistosomiasis (Bilharziasis) 09/2013
1	Hypertrophy 09/2013
1	Cardiomegaly (Heart Hypertrophy) 06/2011
1	Body Weight (Weight, Body) 06/2011
1	Pulmonary Arterial Hypertension 01/2010

Drug/Important Bio-Agent (IBA)

6	MonocrotalineIBA 06/2020 - 01/2010
4	Bleomycin (Blenoxane)FDA LinkGeneric 10/2019 - 10/2015
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2019
3	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022 - 09/2013
3	Chymases (Chymase)IBA 10/2015 - 01/2013
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 01/2017
2	Vasodilator Agents (Vasodilators)IBA 03/2020 - 01/2016
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2018 - 05/2011
1	Cysteine (L-Cysteine)FDA Link 01/2022
1	Surface-Active Agents (Surfactants)IBA 08/2021
1	Tissue Plasminogen Activator (Alteplase)FDA Link 03/2021
1	Doxycycline (Periostat)FDA LinkGeneric 01/2021
1	SmokeIBA 01/2021
1	Iloprost (Ventavis)FDA Link 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	Tadalafil (Cialis)FDA Link 10/2020
1	Semaxinib (SU5416)IBA 10/2020
1	macitentanIBA 10/2020
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2020
1	cadherin 5IBA 10/2019
1	treprostinil FDA Link 10/2019
1	indium-bleomycinIBA 10/2019
1	Epoprostenol (Prostacyclin)FDA LinkGeneric 10/2019
1	6-chloropenicillanic acid S-sulfoxideIBA 01/2019
1	Fibroblast Growth Factor 10IBA 01/2019
1	pirfenidoneIBA 11/2018
1	CollagenIBA 11/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2018
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2018
1	Fibroblast Growth Factor 7 FDA Link 01/2018
1	Therapeutic UsesIBA 01/2017
1	tanespimycin (17AAG)IBA 01/2017
1	Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA 01/2017
1	Histones (Histone)IBA 01/2017
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2017
1	Matrix Metalloproteinases (MMPs)IBA 01/2017
1	17- (dimethylaminoethylamino)- 17- demethoxygeldanamycinIBA 01/2017
1	Sildenafil Citrate (Viagra)FDA Link 01/2016
1	Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA 12/2015
1	NADPH Oxidase 1IBA 12/2013
1	Superoxides (Superoxide)IBA 12/2013
1	Sorafenib (BAY 43-9006)FDA Link 09/2013
1	Sunitinib (Sutent)FDA Link 09/2013
1	Endothelin A ReceptorIBA 06/2011
1	Endothelin-1 (Endothelin 1)IBA 06/2011
1	N- (2- acetyl- 4,6- dimethylphenyl)- 3- (3,4- dimethylisoxazol- 5- ylsulfamoyl)thiophene- 2- carboxamideIBA 06/2011
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2010
1	Epidermal Growth Factor (EGF)IBA 01/2010
1	ErbB Receptors (EGF Receptor)IBA 01/2010
1	Gefitinib (Iressa)FDA Link 01/2010

Therapy/Procedure

4	Therapeutics 10/2021 - 09/2013
1	Noninvasive Ventilation 08/2021
1	Operative Surgical Procedures 01/2017
1	Lung Transplantation 01/2017